BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16735651)

  • 1. Pseudoephedrine laws in the US--are we doing enough?
    Murty S; Sansgiry SS
    Ann Pharmacother; 2006 Jun; 40(6):1213-5. PubMed ID: 16735651
    [No Abstract]   [Full Text] [Related]  

  • 2. Are methamphetamine precursor control laws effective tools to fight the methamphetamine epidemic?
    Nonnemaker J; Engelen M; Shive D
    Health Econ; 2011 May; 20(5):519-31. PubMed ID: 21433216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restricting the sale of pseudoephedrine to prevent methamphetamine production.
    Colker AC
    NCSL Legisbrief; 2005 Feb; 13(7):1-2. PubMed ID: 15726724
    [No Abstract]   [Full Text] [Related]  

  • 5. The meth menace: battling the fast-paced spread of methamphetamine may mean attacking it from several fronts.
    Boulard G
    State Legis; 2005 May; 31(5):14-8. PubMed ID: 15892208
    [No Abstract]   [Full Text] [Related]  

  • 6. Essential/precursor chemicals and drug consumption: impacts of US sodium permanganate and Mexico pseudoephedrine controls on the numbers of US cocaine and methamphetamine users.
    Cunningham JK; Liu LM; Callaghan RC
    Addiction; 2016 Nov; 111(11):1999-2009. PubMed ID: 27529812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting.
    Cunningham JK; Liu LM; Muramoto M
    Addiction; 2008 Jul; 103(7):1174-86. PubMed ID: 18422822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The scourge of methamphetamine.
    Thomas SP
    Issues Ment Health Nurs; 2009 Aug; 30(8):473. PubMed ID: 19591019
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.
    Cunningham JK; Liu LM
    Soc Sci Med; 2008 Apr; 66(7):1463-73. PubMed ID: 18222587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures.
    Cunningham JK; Callaghan RC; Tong D; Liu LM; Li HY; Lattyak WJ
    Drug Alcohol Depend; 2012 Nov; 126(1-2):55-64. PubMed ID: 22592141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of methamphetamine abuse in Missouri.
    Topolski JM
    Mo Med; 2007; 104(1):82-8. PubMed ID: 17410832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Registration requirements for importers and manufacturers of prescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2010 Feb; 75(20):4973-82. PubMed ID: 20352663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The methamphetamine epidemic and dentistry.
    Klasser GD; Epstein JB
    Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexico's methamphetamine precursor chemical interventions: impacts on drug treatment admissions.
    Cunningham JK; Bojorquez I; Campollo O; Liu LM; Maxwell JC
    Addiction; 2010 Nov; 105(11):1973-83. PubMed ID: 20707864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
    Maxwell JC; Rutkowski BA
    Drug Alcohol Rev; 2008 May; 27(3):229-35. PubMed ID: 18368603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why do we need an Addiction supplement focused on methamphetamine?
    Rawson RA; Condon TP
    Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine precursor regulation: are we controlling or diverting the drug problem?
    McKetin R
    Addiction; 2008 Apr; 103(4):521-3. PubMed ID: 18339098
    [No Abstract]   [Full Text] [Related]  

  • 20. Impacts of federal precursor chemical regulations on methamphetamine arrests.
    Cunningham JK; Liu LM
    Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.